SeQuent Scientific Overview

  • Founded
  • 1985
Founded
  • Status
  • Public
  • Employees
  • 504
Employees
  • Stock Symbol
  • 512529
Stock Symbol
  • Investments
  • 5
  • Share Price
  • $1.59
  • (As of Monday Closing)

SeQuent Scientific General Information

Description

Sequent Scientific Ltd is a pharmaceutical company operating animal health and analytical services. It develops API products and formulations. The company's product portfolio includes products across various therapy classes such as antibiotics, anthelmintics, pain management, and nutrition. The company's geographical segment includes North America, Europe, India, Latin America, Turkey, and other Emerging Markets. It generates maximum revenue from North America.

Contact Information

Website
www.sequent.in
Formerly Known As
PI Drugs and Pharmaceuticals
Ownership Status
Publicly Held
Financing Status
Private Equity-Backed
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Stock Exchange
BOM
Primary Office
  • 301/A, 3rd Floor, Dosti Pinnacle
  • Plot No.E7, Road No. 22, Wagle Industrial Area, Thane (West)
  • Mumbai, Maharashtra 400604
  • India
+91 022 0000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

SeQuent Scientific Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.59 $1.68 $1.58 - $4.53 $417M 248M 636K $0.03

SeQuent Scientific Financials Summary

In Thousands,
USD 		TTM 31-Dec-2021 FY 2021 31-Mar-2021 FY 2020 31-Mar-2020 FY 2019 31-Mar-2019
EV 574,456 813,788 292,994 288,485
Revenue 188,119 183,013 165,973 148,488
EBITDA 17,227 28,358 25,180 18,896
Net Income 7,158 12,828 9,839 6,952
Total Assets 189,604 193,933 199,840
Total Debt 0 37,589 53,584 47,674
Public Fundamental Data provided by Morningstar, Inc. disclaimer

SeQuent Scientific Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore SeQuent Scientific‘s full profile, request access.

Request a free trial

SeQuent Scientific Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Sequent Scientific Ltd is a pharmaceutical company operating animal health and analytical services. It develops API prod
Pharmaceuticals
Mumbai, India
504 As of 2021
0000 0000-00-00
000000000000

000000 0

eniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute
0000000000000
Chennai, India
0000 As of 0000
000.00
000000000 000.00

000000 0

do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud
0000000000000
Mumbai, India
0000 As of 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

SeQuent Scientific Competitors (30)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Solara Active Pharma Sciences Corporation Chennai, India 0000 000.00 000000000 000.00
000000 000000 Corporation Mumbai, India 0000
000000000 Corporation Mumbai, India 0000 000000000
000000000 000000 Corporation Hyderabad, India 00000 00000 000000000 00000
000000 00000 Corporation Mumbai, India 0000
You’re viewing 5 of 30 competitors. Get the full list »

SeQuent Scientific Patents

  • 18

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 2

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

SeQuent Scientific Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20140100385-A1 Process for preparation of succinylcholine chloride Abandoned 08-Oct-2012 0000000000
EP-2651225-A2 A process for preparation of praziquantel Withdrawn 13-Dec-2010 0000000000
EP-2651225-A4 A process for preparation of praziquantel Withdrawn 13-Dec-2010 0000000000
US-20130289275-A1 Process for the preparation of praziquantel Granted 13-Dec-2010 0000000000 0
US-8754215-B2 Process for the preparation of praziquantel Active 13-Dec-2010 C07C231/14 0
To view SeQuent Scientific’s complete patent history, request access »

SeQuent Scientific Executive Team (3)

Name Title Board Seat Contact Info
Sharat Narasapur Board Member & Executive
Tushar Mistry Chief Financial Officer
Manish Gupta Board Member & Managing Director
To view SeQuent Scientific’s complete executive team members history, request access »

SeQuent Scientific Board Members (6)

Name Representing Role Since
00000 000000 00.0 Self Chairman & Board Member 000 0000
00000000 000000000 Self Board Member 000 0000
000000 00000 Self Board Member & Managing Director 000 0000
000000 0000000 Self Board Member 000 0000
000000 000000000 SeQuent Scientific Board Member & Executive 000 0000
You’re viewing 5 of 6 board members. Get the full list »

SeQuent Scientific Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SeQuent Scientific Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore SeQuent Scientific‘s full profile, request access.

Request a free trial

SeQuent Scientific Investments & Acquisitions (5)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 000000 01-Jan-2016 0000000000 00.000 Pharmaceuticals 000000 00
0000000 00000 31-Mar-2015 000000000 0000 Pharmaceuticals
00000 0000000 23-May-2014 0000000000 Specialty Chemicals
0000000 00000 01-Jan-2013 00000 0000 Pharmaceuticals
Fraxis Life Sciences 20-Aug-2011 Merger/Acquisition Pharmaceuticals
To view SeQuent Scientific’s complete investments and acquisitions history, request access »

Ready to get started?

Request a free trial

SeQuent Scientific Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000 000000 00000 01-Jan-2016 000000000000000000 00.000 Completed
  • 0000000 0000000000
To view SeQuent Scientific’s complete exits history, request access »